Biodesix, Inc. (NASDAQ:BDSX) Receives $32.50 Average PT from Analysts
Shares of Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation and five have issued a buy recommendation on the company. The average 1-year price target […]
Alvotech (NASDAQ:ALVO) Receives $7.60 Average PT from Analysts
Alvotech (NASDAQ:ALVO – Get Free Report) has been given a consensus rating of “Hold” by the six research firms that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, two have given a hold recommendation and two have given a buy recommendation to the […]
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives $29.22 Average PT from Analysts
Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) has received an average recommendation of “Hold” from the nineteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating, eight have given a buy rating and […]
KALA BIO, Inc. (NASDAQ:KALA) Receives $20.38 Average PT from Analysts
Shares of KALA BIO, Inc. (NASDAQ:KALA – Get Free Report) have been given a consensus recommendation of “Hold” by the six research firms that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has assigned a buy […]
Alkermes plc (NASDAQ:ALKS) Receives $43.93 Average PT from Analysts
Shares of Alkermes plc (NASDAQ:ALKS – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eighteen analysts that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating, eleven have assigned a buy rating and two have assigned a […]
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives $10.80 Average PT from Analysts
Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the […]
Lincoln Electric Holdings, Inc. (NASDAQ:LECO) Receives $302.83 Average PT from Analysts
Lincoln Electric Holdings, Inc. (NASDAQ:LECO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eight brokerages that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the […]
Allegro MicroSystems, Inc. (NASDAQ:ALGM) Receives $45.00 Average PT from Analysts
Allegro MicroSystems, Inc. (NASDAQ:ALGM – Get Free Report) has received an average recommendation of “Moderate Buy” from the twelve brokerages that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and ten have issued a buy recommendation on the company. The […]
Maze Therapeutics, Inc. (NASDAQ:MAZE) Receives $54.63 Average PT from Analysts
Maze Therapeutics, Inc. (NASDAQ:MAZE – Get Free Report) has received a consensus recommendation of “Buy” from the eleven brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, seven have given a buy rating and three have issued a strong buy rating on the […]
last updated on 4 Apr 09:40